“I think it’s really important that people keep signing up to these type of trials to push research forward.”
A study looking at a way to report side effects of treatment online from home (eRAPID RCT)
Coronavirus and cancer
We know it’s a worrying time for people with cancer, we have information to help. If you have symptoms of cancer contact your doctor.
Please note - this trial is no longer recruiting patients. We hope to add results when they are available.
This study is looking at using a computer based system for people to report treatment side effects on line.
Researchers want to find out how useful people having systemic treatment and health professionals find the on line system. They want to see if there are benefits to using this system in comparison with the care people would usually receive.
More about this trial
eRAPID is an online system for people to report their symptoms and side effects during and after cancer treatment. It has already been tested in a study with a small number of people. The researchers now want to test the system with a larger group of people who are having systemic treatment for one of the following cancers
Who can enter
You may be able to join this study if all of the following apply. You
- Have been diagnosed with breast cancer, bowel cancer or a gynaecological cancer
- Are planning to have
systemic treatmentsuch as chemotherapy
- Are able to read and understand English
- Have access to the internet at home
- Are at least 18 years old
You cannot join this study if any of these apply. You
- Are taking part in another clinical trial which includes frequent quality of life study studies
- Have problems with your memory or concentration, or have a mental health problem
- Have taken part in a previous eRAPID study
This study is taking place at St James Hospital in Leeds. The researchers need up to 588 people to take part. The study is randomised. Everyone taking part is put into 1 of 2 groups by a computer. Neither you nor your doctor will be able to decide which group you are in.
People in one group will have usual care during the time they have their treatment. People in the other group will be trained and asked to use the eRAPID symptom questionnaire routinely from home during treatment. This will be in addition to usual care.
If you are in the group using the eRAPID system, a researcher will show you how to complete the online questionnaires. They will give you details of how you log in to the system and a booklet that explains how to use it. They will ask you to log in to the eRAPID system at least once a week during your treatment. You can do this at home.
A friend or relative can help you to use the system, but the researchers would like you to answer the questionnaire yourself. It might also be possible to use the system at the hospital before you have an appointment. Your doctor will be able to look at your answers to the questionnaire and will go through the information either when they see you in clinic or by telephone.
Everyone will be asked to complete some other questionnaires at certain times during the study. These questionnaires will cover your views of your health and treatment, and your quality of life. The researchers are also interested in the financial impact of cancer and so the questionnaires will cover this too.
The study team will also look at your medical notes so they can see how often you had to contact either the hospital or your GP during the time you had treatment.
If you take part in this study there are no additional hospital visits outside of those for your cancer treatment.
There are no side effects associated with this study.
How to join a clinical trial
Professor Galina Velikova
NIHR Clinical Research Network: Cancer
The Leeds Teaching Hospitals NHS Trust
University of Leeds